Correlation Between Rezolute and Crescita Therapeutics
Can any of the company-specific risk be diversified away by investing in both Rezolute and Crescita Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rezolute and Crescita Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rezolute and Crescita Therapeutics, you can compare the effects of market volatilities on Rezolute and Crescita Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rezolute with a short position of Crescita Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rezolute and Crescita Therapeutics.
Diversification Opportunities for Rezolute and Crescita Therapeutics
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Rezolute and Crescita is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Rezolute and Crescita Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crescita Therapeutics and Rezolute is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rezolute are associated (or correlated) with Crescita Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crescita Therapeutics has no effect on the direction of Rezolute i.e., Rezolute and Crescita Therapeutics go up and down completely randomly.
Pair Corralation between Rezolute and Crescita Therapeutics
Given the investment horizon of 90 days Rezolute is expected to generate 7.02 times less return on investment than Crescita Therapeutics. But when comparing it to its historical volatility, Rezolute is 9.08 times less risky than Crescita Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Crescita Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 47.00 in Crescita Therapeutics on August 25, 2024 and sell it today you would lose (2.00) from holding Crescita Therapeutics or give up 4.26% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 99.8% |
| Values | Daily Returns |
Rezolute vs. Crescita Therapeutics
Performance |
| Timeline |
| Rezolute |
| Crescita Therapeutics |
Rezolute and Crescita Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Rezolute and Crescita Therapeutics
The main advantage of trading using opposite Rezolute and Crescita Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rezolute position performs unexpectedly, Crescita Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crescita Therapeutics will offset losses from the drop in Crescita Therapeutics' long position.The idea behind Rezolute and Crescita Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Crescita Therapeutics vs. Amexdrug | Crescita Therapeutics vs. The BC Bud | Crescita Therapeutics vs. Antisense Therapeutics Limited | Crescita Therapeutics vs. Cannara Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |